4basebio (4BB)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

565.00p
   
  • Change Today:
    -10.00p
  • 52 Week High: 1,185.00p
  • 52 Week Low: 520.50p
  • Currency: UK Pounds
  • Shares Issued: 15.54m
  • Volume: 12,017
  • Market Cap: £87.79m

4basebio Overview

4basebio UK Societas ("4bb" or "the Company") is a specialist life sciences group focused on therapeutic DNA for gene therapies and DNA vaccines and providing solutions for effective and safe delivery of these DNA based products to patients. Its main country of operation is the UK. It is the intention of the Company to become a market leader in the manufacture and supply of high purity, synthetic DNA for research, therapeutic and pharmacological use. The principal objective of 4bb is to validate and scale its DNA synthesis process with a view to manufacturing Good Manufacturing Practice ("GMP") grade DNA, suitable for use in gene therapies and DNA vaccines.

1 Day Chart (13-02-2026)

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -1290.7% n/a
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue 94.1 n/a
Pr/Book 3.3  
Latest F'cast
Revenue 84.4% n/a
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

4basebio Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-20 0.46 (0.72) (8.00)p n/a n/a n/a n/a 0.0%
31-Dec-21 0.34 (3.64) (26.00)p n/a n/a n/a n/a 0.0%
31-Dec-22 0.27 (5.93) (0.42)p n/a n/a n/a n/a 0.0%
31-Dec-23 0.51 (8.35) (0.62)p n/a n/a n/a n/a 0.0%
31-Dec-24 0.93 (12.65) (0.94)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

4basebio Company Announcements

4basebio Plc - Director Dealing 11-Feb-2026 15:58 PR Newswire
4basebio Plc - Leadership Changes 10-Feb-2026 07:00 PR Newswire
4basebio Plc - Synthetic opDNA® utilised in... 27-Oct-2025 07:00 PR Newswire

4basebio ShareCast News

4basebio partner starts dosing patients in opDNA... 27-Oct-2025 ShareCast
4basebio reports strong full-year progress 27-May-2025 ShareCast
4basebio's Cambridge facility gets GMP certifica... 02-Apr-2025 ShareCast

Latest 4basebio Director Deals

Traded Action Notifier PriceAmountValue
10-Feb-26 Buy Hansjörg Plaggemars 585.00p 1,000 £5,850.00
10-Feb-26 Buy Heikki Lanckriet 575.82p 3,000 £17,274.60

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

4basebio Market Data

Currency UK Pounds
Share Price 565.00p
Change Today -10.00p
% Change -1.74 %
52 Week High 1,185.00p
52 Week Low 520.50p
Volume 12,017
Shares Issued 15.54m
Market Cap £87.79m

4basebio Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
65.49% below the market average65.49% below the market average65.49% below the market average65.49% below the market average65.49% below the market average
12.20% above the sector average12.20% above the sector average12.20% above the sector average12.20% above the sector average12.20% above the sector average
Price Trend
34.27% below the market average34.27% below the market average34.27% below the market average34.27% below the market average34.27% below the market average
4.55% above the sector average4.55% above the sector average4.55% above the sector average4.55% above the sector average4.55% above the sector average
Income Not Available
Growth
59.11% above the market average59.11% above the market average59.11% above the market average59.11% above the market average59.11% above the market average
65.52% above the sector average65.52% above the sector average65.52% above the sector average65.52% above the sector average65.52% above the sector average

4basebio Dividends

No dividends found

Trades for 13-Feb-2026

Time Volume / Share Price
16:08 2,500 @ 560.00p
16:29 250 @ 569.75p
15:46 9 @ 600.00p
15:46 5 @ 600.00p
15:46 4 @ 600.00p

4basebio Key Personnel

CEO Heikki Lanckriet
CFO David John Roth

Top of Page